Predictors of Pharmacotherapy and Quality of Life Among Patients With Diabetic Foot Syndrome: A Cross-Sectional Study from a Tertiary Care Hospital in India
- 1*,
- 2,
- 3,
- 3
- 1St. John’s Medical College, Sarjapur Road, Bangalore, Karnataka, India.
- 2Department of Endocrinology, St. Johns Medical College, Sarjapur Road, Bangalore, Karnataka, India.
- 3Department of Pharmacology, St. Johns Medical College, Sarjapur Road, Bangalore, Karnataka, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: E. Pasangha
St. John’s Medical College, Sarjapur Road, Bangalore, Karnataka, India.
Email: p_nidhin@hotmail.com
Copyright: © 2022 The Author(s). This is an open access article.
Published: Jan 1, 2022, Received: Dec 20, 2021, Accepted: Feb 12, 2022
Abstract
Objective: To assess the patterns and predictors of pharmacotherapy and QOL in DFS patients in an Indian tertiary care hospital.
Methods: A cross-sectional study was conducted among inpatients with DFS. Data on sociodemographic and clinical factors, pharmacotherapy, clinical outcomes, and QOL were analyzed using the chi-squared test, independent sample t-test, and binary logistic regression.
Results: We screened 3284 inpatients and included consecutive 87 (2.7%) DFS patients. The mean age was 56.08 ± 11.05 years, with a male preponderance (75.8%). Mean HbA1c was 9.9 ± 2.483. About 75% of patients received insulin, and polypharmacy was noticed in 82.7%. About 67.8% of DFS patients had other vascular complications of diabetes, with diabetic retinopathy being the most common in 89%. Amputations were noticed in 32.1% of patients. Overall, poor QOL was seen in 79.3% of patients. The mean scores for different domains were as follows: physical, 41.51 ± 14.15; psychological, 42.90 ± 11.16; social relationships, 43.06 ± 19.36; and environment, 47.17 ± 13. The presence of complications from diabetes was a significant predictor of the utilization of antihypertensives (OR: 2.92, CI [1.09, 7.79], P = 0.03) and poor QOL (OR: 4.54, CI [0.965, 21.41], P = 0.05).
Conclusion: DFS patients in this study were found to be younger with poor glycemic control and other vascular complications of diabetes. The presence of other complications of diabetes in DFS patients was found to be a predictor of pharmacotherapy and poor QOL.
Keywords
Subject
Recommended articles
- Pioglitazone-induced congestive heart failure and pulmonary edema in a patient with preserved ejection fraction
Vaneet Jearath, Rajan Vashisht, Vipul Rustagi · Journal of Pharmacology and Pharmacotherapeutics
- Inhaled insulin: A “puff” than a “shot” before meals
Dick B. S. Brashier, Anjan Khadka, Tejus Anantharamu · Journal of Pharmacology and Pharmacotherapeutics
Readers Also Viewed
Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models
Annisa Fatharani, Ali Alsayegh
Jan 1, 2026
Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review
Mohammad Akbar Hossain
Jan 1, 2026
Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia
Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby
Jan 1, 2026